BioClonal
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Other R&D services
BioClonal is unlocking the future of antibody discovery with RedMab, our proprietary immunization platform powered by next-generation designer super-adjuvants. These unique immune enhancers enable the generation of antibodies against previously untouchable targets—including membrane proteins, low-immunogenic epitopes, and small peptides. Based in Zaragoza, Spain, we empower biopharma partners to reach challenging antigens and accelerate antibody innovation. Our lead program in Alzheimer’s disease targets a novel epitope never before addressed with antibodies—highlighting the first-in-class potential of RedMab.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}